rs1989810
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002470.4(MYH3):c.534-44T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.716 in 1,580,702 control chromosomes in the GnomAD database, including 415,084 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.63 ( 32090 hom., cov: 32)
Exomes 𝑓: 0.72 ( 382994 hom. )
Consequence
MYH3
NM_002470.4 intron
NM_002470.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.434
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
This place is a probable branch point but rather VUS (scored 5 / 10). Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-10649729-A-G is Benign according to our data. Variant chr17-10649729-A-G is described in ClinVar as [Benign]. Clinvar id is 258695.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH3 | NM_002470.4 | c.534-44T>C | intron_variant | ENST00000583535.6 | NP_002461.2 | |||
MYH3 | XM_011523870.4 | c.534-44T>C | intron_variant | XP_011522172.1 | ||||
MYH3 | XM_011523871.3 | c.534-44T>C | intron_variant | XP_011522173.1 | ||||
MYH3 | XM_047436127.1 | c.534-44T>C | intron_variant | XP_047292083.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH3 | ENST00000583535.6 | c.534-44T>C | intron_variant | 5 | NM_002470.4 | ENSP00000464317.1 | ||||
MYH3 | ENST00000579489.2 | n.486-44T>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.630 AC: 95764AN: 151914Hom.: 32081 Cov.: 32
GnomAD3 genomes
AF:
AC:
95764
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.648 AC: 162616AN: 251048Hom.: 55356 AF XY: 0.660 AC XY: 89519AN XY: 135730
GnomAD3 exomes
AF:
AC:
162616
AN:
251048
Hom.:
AF XY:
AC XY:
89519
AN XY:
135730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.725 AC: 1035758AN: 1428670Hom.: 382994 Cov.: 24 AF XY: 0.723 AC XY: 515946AN XY: 713150
GnomAD4 exome
AF:
AC:
1035758
AN:
1428670
Hom.:
Cov.:
24
AF XY:
AC XY:
515946
AN XY:
713150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.630 AC: 95798AN: 152032Hom.: 32090 Cov.: 32 AF XY: 0.623 AC XY: 46328AN XY: 74314
GnomAD4 genome
AF:
AC:
95798
AN:
152032
Hom.:
Cov.:
32
AF XY:
AC XY:
46328
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1739
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Freeman-Sheldon syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Arthrogryposis, distal, type 2B3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at